diabetes

September 13, 2018

Healthy antibodies reverse diabetes

Vanderbilt researchers have discovered that IgM-type antibodies appear to play a protective role to prevent the development of type 1 diabetes — and that purified IgM antibodies can reverse the disease.

By Leigh MacMillan
September 13, 2018

First Islet Workshop draws international audience

More than 200 investigators from across the globe who specialize in islet biology, the study of hormone-producing cell clusters in the pancreas known as islets, recently gathered in Nashville to share knowledge and present the challenges and successes of their work during the first Islet Biology Workshop at Vanderbilt.

By Jill Clendening
September 13, 2018

Research reveals link between immunity, diabetes

When it comes to diet-induced obesity, your immune system is not always your friend.

By Bill Snyder
September 6, 2018

Team’s findings could spur new treatments for type 2 diabetes

An international research team including scientists from Vanderbilt University has discovered how the diabetes drug metformin blocks glucose production by the liver. The discovery, reported Aug. 27 in the journal Nature Medicine, could lead to development of new ways to treat type 2 diabetes.

By Bill Snyder
August 20, 2018

Andie Perona, part of the VUMC transplant team, receives double organ transplant

The transplant team surgical technician found herself on the other side of the table as a kidney and pancreas transplant recipient. It transformed her life.

By Tavia Smith
August 16, 2018

NIDDK director lauds medical student research contributions

Griffin Rodgers, MD, director of the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), was a special guest during the 10th annual NIDDK Medical Student Research Symposium held earlier this month on the Vanderbilt University campus.

By Jill Clendening
July 12, 2018

Team explores diabetes drug’s ability to treat RSV infection

A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.
By Leigh MacMillan
March 23, 2018

Voluntary exercise and energy balance

Non-exercise physical activity has a measurable energy expenditure, which goes down when animals engage in voluntary exercise, Vanderbilt researchers have discovered.
By Leigh MacMillan
March 6, 2018

Discovery by Vanderbilt-led group could lead to improved diabetes treatment

Vanderbilt investigators and colleagues around the country have made a major discovery that could lead to better ways to treat type 1 diabetes (T1D).
By Bill Snyder
January 25, 2018

Study may point to new ways to reverse insulin resistance

Researchers at Vanderbilt University have discovered how insulin crosses the capillary endothelium to exit blood vessels and stimulate skeletal muscle cells — a major finding that may lead to new ways to reverse insulin resistance, a hallmark of type 2 diabetes.
By Bill Snyder
December 14, 2017

Diabetes Day

Research achievement was recognized recently during Diabetes Day at the Student Life Center. Among those honored were (beginning second from left) Bryan Gitschlag, Danielle Dean, PhD, Ian Williams, Caroline Presley, MD, and Suzanne Starr. Award winners are flanked by Tom Elasy, MD, MPH, (left) and Alvin Powers, MD. Diabetes Day was sponsored by the Vanderbilt Diabetes Research and Training Center and the Vanderbilt Center for Diabetes Translation Research and supported by the National Institutes of Health.
By VUMC News and Communications
December 7, 2017

Telemedicine simplifies gestational diabetes treatment

When 32-year-old Dana Shaw was diagnosed with gestational diabetes mellitus (GDM) during her pregnancy with her first child, she was happy to learn she could meet with a physician about the condition through video conferencing rather than taking time off from work for an appointment.
By Jill Clendening
November 9, 2017

New phenotyping program to bolster global diabetes research efforts

The use of human pancreatic islets to conduct diabetes-related research has greatly expanded in recent years, and a Human Islet Phenotyping Program (HIPP) at Vanderbilt University Medical Center has been established to provide important islet data to investigators worldwide.
By Jill Clendening